Taro Pharmaceutical Industries Ltd. Ordinary Shares (TARO): Price and Financial Metrics


Taro Pharmaceutical Industries Ltd. Ordinary Shares (TARO)

Today's Latest Price: $54.85 USD

0.32 (0.59%)

Updated Sep 30 7:00pm

Add TARO to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 239 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

TARO Stock Summary

  • TARO's went public 27.35 years ago, making it older than 77.35% of listed US stocks we're tracking.
  • For TARO, its debt to operating expenses ratio is greater than that reported by only 0.32% of US equities we're observing.
  • TARO's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of just 8.51% of US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Taro Pharmaceutical Industries Ltd are OPTT, AMSC, CBLI, SPNS, and SCON.
  • TARO's SEC filings can be seen here. And to visit Taro Pharmaceutical Industries Ltd's official web site, go to www.taro.com.
TARO Daily Price Range
TARO 52-Week Price Range

TARO Stock Price Chart Technical Analysis Charts


TARO Price/Volume Stats

Current price $54.85 52-week high $99.69
Prev. close $54.53 52-week low $53.95
Day low $54.38 Volume 19,294
Day high $54.98 Avg. volume 37,366
50-day MA $61.05 Dividend yield N/A
200-day MA $69.00 Market Cap 2.10B

Taro Pharmaceutical Industries Ltd. Ordinary Shares (TARO) Company Bio


Taro Pharmaceutical Industries offers prescription and over-the-counter pharmaceutical products focusing on primary areas, including topical creams and ointments, liquids, capsules, and tablets in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories. The company was founded in 1959 and is based in Haifa Bay, Israel.


TARO Latest News Stream


Event/Time News Detail
Loading, please wait...

TARO Latest Social Stream


Loading social stream, please wait...

View Full TARO Social Stream

Latest TARO News From Around the Web

Below are the latest news stories about Taro Pharmaceutical Industries Ltd that investors may wish to consider to help them evaluate TARO as an investment opportunity.

Taro Pharmaceutical launches generic Deferiprone in U.S.

Taro Pharmaceutical ([[TARO]] -0.5%) has announced the launch of deferiprone, a generic version of Chiesi's Ferriprox, an iron chelator indicated for transfusional iron overload due to thalassemia syndromes, when current chelation therapy is not sufficient.The company will team up with BioPlus Specialty Pharmacy for distribution of deferiprone tablets at launch....

Seeking Alpha | September 28, 2020

Legal woes, decline in sales hurt Sun Pharma: Q1 key takeaways

NEW DELHI: Hurt by one-time loss, leading drugmaker Sun Pharma reported a surprising loss during the June quarter while sales declined in all regions of the world the company operates in.However, the management hailed the company's performance. They said it has done well given the challenges it faced and managed to hold its market share in India and the US.How much did the company earn?Sun Pharma reported a loss of Rs 1,655.60 crore in the quarter, sharply lower from the expectation as it recognised an exceptional item. The company’s revenues from operations also fell to Rs 7,467.19 crore, from Rs 8,259.30 crore a year ago. EBITDA was at Rs 1,725 crores, with resulting EBITDA margin of 23.1 per cent.What is that exceptional item?The company reported a one-time loss of Rs 3,633.33 crore ...

Economic Times India | July 31, 2020

Sun Pharma to acquire Canada's Aquinox Pharmaceuticals

Sun Pharmaceutical Industries on Wednesday said that a wholly-owned subsidiary of Taro Pharmaceutical Industries Ltd will acquire Aquinox Pharmaceuticals (Canada) Inc for $8.2 million.

India TV News | July 29, 2020

Sun Pharma to acquire Canada-based Aquinox Pharmaceuticals for $8.2m

Sun Pharmaceutical Industries has announced that one of the fully-owned subsidiaries of Taro Pharmaceutical Industries Ltd is about to to acquire Aquinox Pharmaceuticals (Canada) Inc for $8.2 milli…

Nigerian-Canadian News | July 29, 2020

Sun Pharma's Subsidiary Taro Pharma To Acquire Canada's Aquinox Pharma

On Wednesday, in a stock exchange filing, Sun Pharma said that a subsidiary of its American arm Taro Pharmaceutical will acquire Canada's Aquinox Pharmaceutical for $8.2 million (approx Rs 61.35 crore) in cash. Aquinox Pharmaceuticals is a corporation organised

Goodreturns | July 29, 2020

Read More 'TARO' Stories Here

TARO Price Returns

1-mo -10.39%
3-mo -18.68%
6-mo -13.21%
1-year -26.42%
3-year -51.33%
5-year -62.22%
YTD -37.62%
2019 3.89%
2018 -19.17%
2017 -0.53%
2016 -31.89%
2015 4.29%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.8334 seconds.